Search Results

Displaying Results 4601-4625 of 6996 "'AIM'"

Oct 20, 2025, 12:54 ET Blockchain for Good Alliance and UNDP AltFinLab Launch Blockchain Impact Forum

The Blockchain for Good Alliance (BGA) is a long-term collaborative non-profit initiative with key partners with the main aim to contribute to societal good by using blockchain technology to solve real world problems. By convening leaders, innovators, and organisations from

More news about: Blockchain for Good Alliance (BGA)


Oct 20, 2025, 12:22 ET Xactus Announces Strategic Partnership with Plaid to Expand Intelligent Verification Options for Mortgage Lenders

Underwriter® (DU®) validation service and Freddie Mac's Loan Product Advisor® (LPA®) asset and income modeler (AIM). "Our goal has always been to enable lenders to make better mortgage decisions faster," said Mike Brown, Chief Product Officer

More news about: Xactus


Oct 20, 2025, 10:23 ET Kanazawa University Research: From Molecular Interactions to Material Function: Unraveling Water's Effect on Chitin Nanocrystals

behavior and dynamics of important macromolecules in living organisms, such as proteins and nucleic acids, at the surface and interior of cells. We aim at acquiring a fundamental understanding of the various life phenomena at the nanoscale.

More news about: Kanazawa University


Oct 20, 2025, 09:38 ET XPPen Unveils Stunning New Artist 12 3rd with X-Dial Shortcut Keys and Upgraded X4 Smart Chip Stylus

stylus delivers significantly more processing power that translates to a faster response rate, heightened sensitivity, and exceptional precision. Our aim is to bridge the gap for entry-level creators and those who value portability by offering a device that doesn't compromise on professional performance." 

More news about: XPPen Technology Co., Ltd.


Oct 20, 2025, 09:38 ET XPPen Unveils Stunning New Artist 12 3rd with X-Dial Shortcut Keys and Upgraded X4 Smart Chip Stylus

stylus delivers significantly more processing power that translates to a faster response rate, heightened sensitivity, and exceptional precision. Our aim is to bridge the gap for entry-level creators and those who value portability by offering a device that doesn't compromise on professional performance." 

More news about: XPPen Technology Co., Ltd.


Oct 20, 2025, 08:58 ET Widex and Signia Unite and Expand Commercial and Sales Teams in the US to Give HCPs One Relationship, Two Industry-Leading Brands, and More Time for Patient Care

perfect.  About SigniaSignia, a part of WSA, is one of the world's leading hearing aid brands. We aim to enhance human performance through iconic innovations and consumer-friendly designs that shape the hearing health market. Since its launch in 2016,

More news about: WS Audiology


Oct 20, 2025, 08:46 ET K-Food Fever Expands Across the U.S. -- aT Accelerates Export Growth Through "2025 K-Food Fair B2B" in Los Angeles

"The United States is the world's largest export market for K-Food. By connecting K-Food with K-Content fandom and lifestyle trends, we aim to create new global opportunities and strengthen the ongoing K-Food wave." aT plans to continue building on the momentum of K-Food's

More news about: aT Center LA


Oct 20, 2025, 08:00 ET HealthVerity and Claritas Rx announce strategic partnership to unlock more actionable real-world insights for commercial, RWE, and HEOR teams

lab data—from HealthVerity with deeply specialized data on specialty pharmacy (SP), hub, and co-pay programs from Claritas Rx. Together, the companies aim to provide pharmaceutical manufacturers with an integrated, privacy-protected dataset that offers unmatched insight into treatment access, speed-to-therapy,

More news about: HealthVerity, Inc.


Oct 20, 2025, 08:00 ET The results of the EMPRESS study show the activity of giredestrant in reducing tumor proliferation in ER+/HER2- breast cancer at early stages without the need for ovarian function suppression

research partners to benefit from the best of both worlds: industry clinical research and investigator-driven trials.      With the aim of promoting independent research worldwide, MEDSIR has formed a strategic alliance with Oncoclínicas, the leading oncology group in Brazil, which offers

More news about: MEDSIR


Oct 20, 2025, 07:22 ET Taman Safari Indonesia: Immersing in the Tropical Wonders of Indonesia

cultural heritage," said Alexander Zulkarnain, ACT CMO of Taman Safari Indonesia Group. "Through Taman Safari Bogor and Marine Safari Bali, we aim to create experiences that not only entertain but also enrich the soul and bring visitors closer to the wonders of wildlife." As

More news about: Taman Safari Indonesia (TSI)


Oct 20, 2025, 06:30 ET GRAIL, Inc. Announces $325.0 Million Private Placement Financing

This press release contains forward-looking statements. In some cases, you can identify these statements by forward-looking words such as "aim," "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "potential," "predict," "should," "would," or

More news about: GRAIL, Inc.


Oct 20, 2025, 06:16 ET ACG METALS LIMITED: Q3 2025 YTD Operations and Capital Structure Update

"forward-looking statements").  Forward-looking statements are identified by their use of terms and phrases such as "believe", "targets", "expects", "aim", "anticipate", "project", "would", "could", "envisage", "estimate", "intend", "may", "plan", "will" or the negative of those, variations or comparable

More news about: ACG METALS LIMITED


Oct 20, 2025, 06:00 ET GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri® Multi-Cancer Early Detection Test in Symptomatic Individuals at the Early Detection of Cancer Conference (EDCC)

This press release contains forward-looking statements. In some cases, you can identify these statements by forward-looking words such as "aim," "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "potential," "predict," "should," "would," or

More news about: GRAIL, Inc.


Oct 20, 2025, 05:00 ET FDA Grants Orphan Drug Designation to Cellenkos' CK0803 Tregs for Treatment of Amyotrophic Lateral Sclerosis

this rare disease", said Dr. Simrit Parmar, MD, Founder of Cellenkos. Dr. Parmar is also faculty at Texas A&M School of Engineering Medicine. "We aim to deliver a transformative therapeutic that can slow disease progression in ALS, and decrease levels of plasma neurofilament, a biomarker of active

More news about: Cellenkos, Inc.


Oct 20, 2025, 04:14 ET Xinhua Silk Road: China's Tianjin, Jilin and Guangdong unveil joint proposal to deepen exchanges and cooperation in agriculture

According to the proposal, the three regions will focus on key areas such as information sharing, standard setting, and market connectivity, with the aim of improving cooperation mechanisms and exploring new models for cross-regional development in agriculture. In the future, the

More news about: Xinhua Silk Road


Oct 20, 2025, 03:00 ET AP Pension selects Cognizant for BPO and RPA-services as part of multi-year transformation

Through the new collaboration, Cognizant will deliver business process outsourcing and RPA-services to AP Pension with the aim to strengthen capacity, improve efficiency and provide an even better customer experience.

More news about: Cognizant Technology Solutions Corporation


Oct 20, 2025, 03:00 ET AP Pension selects Cognizant for BPO and RPA-services as part of multi-year transformation

Through the new collaboration, Cognizant will deliver business process outsourcing and RPA-services to AP Pension with the aim to strengthen capacity, improve efficiency and provide an even better customer experience.

More news about: Cognizant Technology Solutions Corporation


Oct 20, 2025, 02:53 ET Sharjah Concludes Its Participation in GITEX 2025, Reinforcing Its Leadership in Global Digital Excellence

featured pioneering digital solutions powered by artificial intelligence, data, the Internet of Things, and geospatial technologies. These innovations aim to deliver advanced services that place people at the heart of innovation, leverage emerging technologies to support decision-making, strengthen trust

More news about: Sharjah Digital Department (SDD)


Oct 20, 2025, 02:16 ET From Corporate Social Responsibility To Global Consensus: Chery's "Ride Green Life" Unites the World for a Sustainable Future

Life is a philanthropic practice that Chery has been upholding for many years. This year's cycling event is bigger in scale and more diversified. We aim to make Ride Green Life an influential, environmentally friendly public campaign, convey the Green idea and join hands with more people to protect our

More news about: Chery International


Oct 20, 2025, 01:00 ET Zeekr Group to Report Third Quarter 2025 Financial Results on November 17, 2025

In some cases, forward-looking statements can be identified by words or phrases such as "may," "will," "expect," "anticipate," "future," "target," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to," or other similar expressions. Further information regarding these

More news about: ZEEKR Intelligent Technology Holding Limited


Oct 19, 2025, 19:00 ET Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances

are based on the beliefs of our management as well as assumptions made by and information currently available to our management. When used, the words "aim," "anticipate," "believe," "could," "estimate," "expect," "going forward," "intend," "may," "might," "ought to," "plan," "potential," "predict," "project,"

More news about: Clover Biopharma


Oct 19, 2025, 10:05 ET Global Times: Over 400 senior guests from over 30 countries, regions to attend conference of Financial Street Forum 2025 in Beijing: organizers

system has been upgraded with enhanced online interaction features, making it easier for attendees to communicate during the event. These improvements aim to facilitate more meaningful exchanges and collaborations.  Beyond the formal sessions, the organizers will host a range of evening

More news about: Global Times


Oct 19, 2025, 10:02 ET Spinogenix Announces Publication of Preclinical Study Demonstrating Neuroprotective Effects of SPG302 in a Model of Glaucoma

glaucoma are linked to high pressure, and existing therapies have limitations. As a result, there is growing interest in new treatment strategies that aim to protect and regenerate damaged neurons to preserve or restore vision. Synapse loss in the retina precedes symptoms and neural death, raising the prospect

More news about: Spinogenix


Oct 18, 2025, 06:00 ET Nuvalent Presents Preliminary Data for Neladalkib in Advanced ALK-positive Solid Tumors Beyond NSCLC at ESMO 2025

About Neladalkib Neladalkib is an investigational brain-penetrant ALK-selective inhibitor created with the aim to overcome limitations observed with currently available ALK inhibitors. Neladalkib is designed to remain active in tumors that have developed resistance

More news about: Nuvalent, Inc.


Oct 18, 2025, 05:03 ET GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings

translating to a false positive rate of only 0.4%. "Any multi-cancer early detection test used for population screening should aim to detect as many aggressive cancers as possible before symptoms arise and maximize the likelihood that a positive test result is actually cancer. The

More news about: GRAIL, Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.